Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19-Reference-Cited by-同舟云学术

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19

Published:2021-01 Issue:1 Volume:7 Page:16-25
ISSN:2405-500X
Container-title:JACC: Clinical Electrophysiology
language:en
Short-container-title:JACC: Clinical Electrophysiology

Author:

O’Connell Thomas F.,Bradley Christopher J.,Abbas Amr E.,Williamson Brian D.,Rusia Akash,Tawney Adam M.,Gaines Rick,Schott Jason,Dmitrienko Alex,Haines David E.

Publisher

Elsevier BV

Reference31 articles.

1. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia;Li;N Engl J Med,2020

2. Covid-19 in critically ill patients in the Seattle region – case series;Bhatraju;N Engl J Med,2020

3. Race to find COVID-19 treatments accelerates;Kupferschmidt;Science,2020

4. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;Wang;Cell Res,2020

5. Evaluation of Ebola virus inhibitors for drug repurposing;Madrid;ACS Infect Dis,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evaluation of the short-term and long-term hydroxychloroquine therapy on ECG parameters;Medicine;2024-08-09

2. Prevalence, Outcomes, and Predictors of Prolonged Corrected QT Interval in Hydroxychloroquine-Naïve Hospitalized COVID-19 Patients;Cardiovascular Toxicology;2024-07-02

3. Hydroxychloroquine-azithromycin, doubase C, and QTc prolongation in congolese patients with COVID-19: Myth or reality?;World Journal of Virology;2024-06-25

4. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association;Circulation;2024-02-20

5. Potential Signals of COVID-19 as an Effect Modifier of Adverse Drug Reactions;Clinical Therapeutics;2024-01